Need to keep on prime of the science and politics driving biotech at this time? Enroll to get our biotech e-newsletter in your inbox.
It’s only a mouse research, however intriguing all the identical: Lithium could present promise as an Alzheimer’s remedy. Additionally, Eli Lilly’s oral weight reduction capsule falls in need of GLP-1 stalwarts, and extra.
The necessity-to-know this morning
- Strand Therapeutics, a privately held developer of most cancers medicine, raised $153 million in a Sequence B spherical of financing. The corporate intends to make use of the cash to advance the event of an mRNA-based drug at present in early stage research for the remedy of strong tumors.
Eli Lilly’s key weight problems capsule falls in need of rivals
Eli Lilly mentioned this morning that its experimental weight problems capsule orforglipron fell in need of expectations in a late-stage trial, delivering 11.2% weight reduction over 72 weeks — lower than the 15% to 21% reductions seen with injectables like Wegovy and Zepbound.
